[IMNM] One Big Step Closer To Escape Velocity
The latest data out of Immunome underscores the superiority of its approach and demonstrates why the stock could be the next high-flying Novavax (NVAX)
The latest data out of Immunome underscores the superiority of its approach and demonstrates why the stock could be the next high-flying Novavax (NVAX)
To invest in biotech is to invest in the future. And with this unique, under-the-radar company, we can do so with dramatically reduced risk
The latest data out of Immunome underscores the superiority of its approach and demonstrates why the stock could be the next high-flying Novavax (NVAX)
The latest data out of Immunome underscores the superiority of its approach and adds urgency to the opportunity. Here’s why…
With micro-caps surging and the Covid-19 pandemic underscoring the vital need for new drugs and therapies, this micro-cap is perfectly positioned to capitalize on the momentum in both areas of the market.